Effect of Troglitazone on expression of adhesion molecules and eNOS in human saphenous vein gaft

Abstract

To investigate whether peroxisome proliferators-activated receptor-γ (PPARγ) ligand Troglitazone can reduce endothelial injury and activation during storage of harvested saphenous vein grafts. Segments of human saphenous vein graft were collected from 9 patients undergoing coronary bypass surgery and then divided into two equal parts of control and test specimens, were stored in either heparinized blood (control group) or heparinized blood containing 20 μmol/L troglitazone (test group) for 1 h at room temperature. Tissue distribution and protein expression of VCAM-1, ICAM-1, and endothelial nitric oxide synthase (eNOS) were compared using immunohistochemistry and Western blot analysis. Myeloperoxidase (MPO) activity, a marker of neutrophil sequestration in human saphenous vein grafts, was also measured in each group. The expression of ICAM-1 (753±132 versus 7201±934; P<0.01), VCAM-1 (3731±294 versus 8292±793; P<0.01), and MPO activity (1.52±0.42 U/g, 5.04±1.26 U/g P<0.01) were significantly lower in test group. In contract, eNOS expression (7983±834 versus 3989±1008; P<0.01) was significantly higher in test group. PPARγ ligand troglitazone might reduce endothelial injury during the storage period of human saphenous vein grafts.

Keywords

Troglitazone / adhesion molecule / endothelial nitric oxide synthase / saphenous vein / graft

References

[1] ThatteH. S., KhuriS. F.. The coronary artery bypass conduit: I. Intraoperative endothelial injury and its implication on graft patency. Ann Thorac Surg, 2001, 72: S2245-S2252

[2] HsuehW. A., JacksonS., LawR. E.. Control of vascular cell proliferation and migration by PPAR Ɣ. Diabetes Care, 2001, 24: 392-397

[3] TsuiJ. C., SouzaD. S., FilbeyD., et al.. Preserved endothelial intergrity and nitric oxide synthase in saphenous vein grafts harvested by a “no-touch” technique. Br J Surg, 2001, 88: 1209-1215

[4] ThatteH. S., BiswasK. S., NajjarS. F., et al.. Multi-photon microscopic evaluation of saphenous vein endothelium and its preservation with a new solution, GALA. Ann Thorac Surg, 2003, 75: 1145-1152

[5] PolikandriotisJ. A., MazzellaL. J., RupnowH. L., et al.. Peroxisome proliferators-activated receptor γ ligands stimulate endothelial nitric oxide production through distinct peroxisome proliferators-activated receptor γ-dependent mechanisms. Arterioscler Thromb Vasc Biol, 2005, 25: 1810-1816

[6] GoyaK., SumitaniS., OtsukiM., et al.. The thiazolidinedione drug troglitazone up-regulates nitric oxide synthase expression in vascular endothelial cells. J Diabetes Complications, 2006, 20: 336-342

[7] SchaefferU., TannerB., StrohschneiderT., et al.. Damage to arterial and venous endothelial cells in bypass grafts induced by several solution used in bypass surgery. Thoarc Cardiovasc Surg, 1997, 45: 168-171

[8] JacksonS. M., ParhamiF., XiX. P., et al.. Peroxisome proliferators-activated receptor activators target human endothelial cells to inhibit leucocyte-endothelial cell interaction. Arterioscler Thromb Vasc Biol, 1999, 19: 2094-2506

[9] SpoeckerM., DariusH., KabothK., et al.. Differential regulation of endothelial cell adhesion molecule expression by nitric oxide donors and antioxidants. J Leukoc Biol, 1998, 63: 732-739